Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma

World Journal of Gastroenterology

Volumn 17, Issue 41, 2011, Pages 4640-4642

  Krawczyk, Marcin ^a   Mihalache, Florentina ^a,b   Höblinger, Aksana ^c   Acalovschi, Monica ^b   Lammert, Frank ^a   Zimmer, Vincent ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ABO; Biliary tract cancer; Blood groups; Genetic risk; Single nucleotide polymorphism

Indexed keywords

BILE DUCT CARCINOMA; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; CONTINGENCY TABLE; CONTROLLED STUDY; DNA DETERMINATION; EUROPE; EUROPEAN AMERICAN; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR LOCALIZATION;

EID: 80355132091     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i41.4640     Document Type: Letter

References (7)

1. Greer JB, Yazer MH, Raval JS, Barmada MM, Brand RE, Whitcomb DC. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol 2010; 16: 5588-5591
2. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009; 41: 986-990
3. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis 2008; 12: 131-150, ix
4. Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004; 23: 6471-6476
5. Mihalache F, Höblinger A, Grünhage F, Krawczyk M, Gärtner BC, Acalovschi M, Sauerbruch T, Lammert F, Zimmer V. Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharmacol Ther 2011; 33: 389-394
6. Grover VK, Cole DE, Hamilton DC. Attributing Hardy-Weinberg disequilibrium to population stratification and genetic association in case-control studies. Ann Hum Genet 2010; 74: 77-87
7. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer 2010; 46: 3345-3350